Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0155
+0.0051 (49.61%)
Sep 12, 2025, 3:57 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
PHEXXI and SOLOSEC
19.36M
Log In
Log In
Log In
Log In
Upgrade
PHEXXI and SOLOSEC Growth
6.28%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
United States
19.36M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
6.28%
Log In
Log In
Log In
Log In
Upgrade